Research Database
Linking variants to function: understanding the genetics of type 2 diabetes through multi-omic data
Debora Rodrigues, PhD
Institution:
David Geffen School of Medicine at University of California, Los Angeles
Grant Number:
1-24-ACE-21
Type of Grant:
Basic
Diabetes Type:
Type 2 Diabetes
Therapeutic Goal:
Prevent Diabetes
Focus:
Project Date:
-
Project Status:
active

Research Description

Type 2 Diabetes (T2D) is a widespread health concern, affecting around 10% of the U.S. population. It is a complex condition influenced by both our environment and our genes. While some rare genetic mutations can have significant effects on T2D, most cases are thought to result from a combination of common genetic variants, each contributing a small effect to the overall risk of developing the disease. These common genetic variants have been identified through large-scale studies called GWAS. They have helped reveal new genes and pathways linked to T2D. However, understanding how these genetic variants function and impact T2D risk poses a challenge. The Sobreira lab proposes an innovative study using cutting-edge technologies like data science, single-cell analysis, disease modeling, induced pluripotent stem cells, and genetic screening. By analyzing genetic associations in various tissues relevant to T2D, the researchers aim to uncover the functional implications of these genetic variants. The main goal is to bridge the gap between genetic signals and T2D development, shedding light on novel genes, cellular pathways, and signaling mechanisms associated with the disease. Integrating advanced methodologies, this research aims to translate genetic findings into meaningful biological knowledge and strives to pave the way for the development of innovative strategies for predicting and preventing T2D. Ultimately, these efforts could significantly impact clinical management and improve the lives of individuals at risk of, or already affected by, T2D. The research brings hope for a brighter future in the fight against this prevalent health condition.

Research Profile

What area of diabetes research does your project cover? What role will this particular project play in preventing, treating and/or curing diabetes?

Dr. Sobreira's research utilizes human genetics to comprehend the fundamental processes in the development of type 2 diabetes. Through a combination of human genetics and comprehensive molecular and epigenetic characterization of key tissues implicated in Type 2 Diabetes and related diseases, the Sobreira lab aims to uncover novel insights into disease biology and progression. These findings will inform more effective preventive and therapeutic approaches, ultimately reducing the burden of the disease, enhancing the overall well-being of individuals affected by diabetes.

If a person with diabetes were to ask you how your project will help them in the future, how would you respond?

If someone with diabetes asked about the impact of my project, I would highlight its focus on practical improvements in diabetes prediction, treatment, and management. Our research aims to understand how Type 2 Diabetes and related diseases develop, allowing us to predict and prevent them. This could lead to targeted drugs and personalized treatment strategies, ultimately improving the overall effectiveness of diabetes care. The goal is to offer individuals a more tailored approach based on their unique characteristics and genetic background for better outcomes, an improved quality of life, and more personalized care.

Why important for you, personally, to become involved in diabetes research? What role will this award play?

For me, the importance of becoming involved in diabetes research stems from a deeply personal connection to the impact of this disease on individuals and communities. Witnessing the challenges faced by friends and family members affected by diabetes has fueled my determination to contribute meaningfully to understanding and addressing this health issue. This award holds a crucial role in my research efforts. Firstly, it provides essential financial support, enabling me to access resources, laboratory equipment, and technology necessary for conducting high-quality research. Moreover, the recognition associated with the award enhances the visibility of my work, opening doors to collaborations, networking opportunities, and a broader platform to share research findings. Ultimately, the award not only facilitates the advancement of my research endeavors but also represents a significant step toward making tangible contributions to diabetes research, with the goal of improving preventive and therapeutic strategies and reducing the burden of this prevalent and impactful disease.

In what direction do you see the future of diabetes research going?

The future of diabetes research is looking promising. Scientists are using genetics and molecular research to create personalized treatments based on individual genetic profiles. They're also working on ways to prevent diabetes by spotting early signs and risks. New therapies, like better drugs with fewer side effects, are being developed. Researchers from different fields are teaming up to understand diabetes better. There's a global effort, with researchers sharing information internationally to speed up progress. In simple terms, diabetes research is moving towards personalized care, better treatments, and teamwork to face the challenges of diabetes.